{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T02:02:31Z","timestamp":1790301751045,"version":"4.1.0"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"UK Medical Research Council","doi-asserted-by":"publisher","award":["MR\/P022669\/1"],"award-info":[{"award-number":["MR\/P022669\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Medical Research Council CMBI Clinical Research Training Fellowship"},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018336","name":"Health Protection Research Unit","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018336","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Healthcare Associated Infections"},{"name":"Antimicrobial Resistance"},{"DOI":"10.13039\/501100000761","name":"Imperial College London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000761","id-type":"DOI","asserted-by":"publisher"}]},{"name":"UK Health Security Agency"},{"name":"Imperial Healthcare Partners"},{"DOI":"10.13039\/501100000735","name":"University of Cambridge","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000741","name":"University of Warwick","doi-asserted-by":"publisher","award":["NIHR200876"],"award-info":[{"award-number":["NIHR200876"]}],"id":[{"id":"10.13039\/501100000741","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The M1UK sublineage of Streptococcus pyogenes has driven recent post-pandemic surges in invasive group A streptococcal (iGAS) disease. We assessed case fatality rate (CFR) among patients with emm1 iGAS in England and Wales, and then compared outcomes associated with M1UK and ancestral emm1 lineages.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We linked emm1 iGAS cases (December 2009\u2013July 2022) with demographic and mortality records. Lineage was determined for isolates collected in 2010, 2013\u20132016, and 2020 via whole-genome sequencing or allele-specific PCR. Seven- and 30-day all-cause CFRs were estimated. Univariate and multivariate models assessed the association between lineage and risk of death.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 4952 emm1 iGAS cases, lineage was assigned to 1356. The 30-day CFR was 24.4% for M1UK, 22.3% for M1global, 10.5% for M123SNP, and 10.3% for M113SNP. After adjustment for age and sex, lineage was not a significant predictor of 7- or 30-day mortality. Survival analysis showed rapid progression to death in both M1UK and M1global cases: 63.7% of deaths occurred within 1 day of diagnostic sampling. Among children under 15 years, 56.3% of fatal cases died before sampling, and 95.6% within 1 day of sampling.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Mortality did not differ significantly between M1UK and M1global lineages, but more studies are required. Overall mortality from emm1 S. pyogenes remains strikingly high. The rapid time to death underscores the need for preventive measures and rapid diagnostic tools that act prior to culture-based confirmation, and highlights challenges for clinical trial design in iGAS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/cid\/ciaf492","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T11:50:04Z","timestamp":1756986604000},"page":"e277-e284","source":"Crossref","is-referenced-by-count":5,"title":["Mortality Among Patients With Invasive Group A Streptococcal Infections Caused by the M1UK Lineage: A Retrospective Cohort Study in England and Wales"],"prefix":"10.1093","volume":"81","author":[{"given":"Ho Kwong","family":"Li","sequence":"first","affiliation":[{"name":"Centre for Bacterial Resistance Biology, Imperial College London , London ,","place":["UK"]},{"name":"Department of Infectious Disease, Imperial College London , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, Imperial College London , London ,","place":["UK"]},{"name":"Centre for Antimicrobial Optimisation, Imperial College London , London ,","place":["UK"]},{"name":"NIHR Health Protection Research Unit in Healthcare-Associated Infections and AMR, Imperial College London , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Waddell","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, Imperial College London , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"Coelho","sequence":"additional","affiliation":[{"name":"NIHR Health Protection Research Unit in Healthcare-Associated Infections and AMR, Imperial College London , London ,","place":["UK"]},{"name":"Staphylococcus and Streptococcus Reference Section, AMRHAI, UK Health Security Agency , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Daniel","sequence":"additional","affiliation":[{"name":"Staphylococcus and Streptococcus Reference Section, AMRHAI, UK Health Security Agency , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca L","family":"Guy","sequence":"additional","affiliation":[{"name":"Antimicrobial Resistance and Healthcare Associated Infections Division, UK Health Security Agency , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3965-8323","authenticated-orcid":false,"given":"Theresa","family":"Lamagni","sequence":"additional","affiliation":[{"name":"NIHR Health Protection Research Unit in Healthcare-Associated Infections and AMR, Imperial College London , London ,","place":["UK"]},{"name":"Antimicrobial Resistance and Healthcare Associated Infections Division, UK Health Security Agency , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5214-4941","authenticated-orcid":false,"given":"Shiranee","family":"Sriskandan","sequence":"additional","affiliation":[{"name":"Centre for Bacterial Resistance Biology, Imperial College London , London ,","place":["UK"]},{"name":"Department of Infectious Disease, Imperial College London , London ,","place":["UK"]},{"name":"NIHR Health Protection Research Unit in Healthcare-Associated Infections and AMR, Imperial College London , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,10,16]]},"reference":[{"key":"2025122403241795900_ciaf492-B1","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1001\/jama.2025.0910","article-title":"Invasive group A streptococcal infections in 10 US states","volume":"333","author":"Gregory","year":"2025","journal-title":"JAMA"},{"key":"2025122403241795900_ciaf492-B2","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1128\/JCM.02155-08","article-title":"Clinical and microbiological characteristics of severe Streptococcus pyogenes disease in Europe","volume":"47","author":"Luca-Harari","year":"2009","journal-title":"J Clin Microbiol"},{"key":"2025122403241795900_ciaf492-B3","author":"WHO","year":"2022"},{"key":"2025122403241795900_ciaf492-B4","author":"Pan American Health Organization\/World Health Organization"},{"key":"2025122403241795900_ciaf492-B5","doi-asserted-by":"crossref","first-page":"2200942","DOI":"10.2807\/1560-7917.ES.2023.28.1.2200942","article-title":"Increase in invasive group A streptococcal infection notifications, England, 2022","volume":"28","author":"Guy","year":"2023","journal-title":"Euro Surveill"},{"key":"2025122403241795900_ciaf492-B6","doi-asserted-by":"crossref","first-page":"e0076624","DOI":"10.1128\/jcm.00766-24","article-title":"Nationwide upsurge in invasive disease in the context of longitudinal surveillance of carriage and invasive Streptococcus pyogenes 2009-2023, The Netherlands: a molecular epidemiological study","volume":"62","author":"R\u00fcmke","year":"2024","journal-title":"J Clin Microbiol"},{"key":"2025122403241795900_ciaf492-B7","doi-asserted-by":"crossref","first-page":"2300422","DOI":"10.2807\/1560-7917.ES.2023.28.36.2300422","article-title":"Increase in bloodstream infections caused by emm1 group A Streptococcus correlates with emergence of toxigenic M1UK, Belgium, may 2022 to August 2023","volume":"28","author":"Rodriguez-Ruiz","year":"2023","journal-title":"Euro Surveill"},{"key":"2025122403241795900_ciaf492-B8","doi-asserted-by":"crossref","first-page":"2300427","DOI":"10.2807\/1560-7917.ES.2023.28.36.2300427","article-title":"Sustained increase of paediatric invasive Streptococcus pyogenes infections dominated by M1UK and diverse emm12 isolates, Portugal, September 2022 to May 2023","volume":"28","author":"Gouveia","year":"2023","journal-title":"Euro Surveill"},{"key":"2025122403241795900_ciaf492-B9","doi-asserted-by":"crossref","first-page":"2300291","DOI":"10.2807\/1560-7917.ES.2023.28.26.2300291","article-title":"Increase in invasive group A streptococcal infections and emergence of novel, rapidly expanding sub-lineage of the virulent Streptococcus pyogenes M1 clone, Denmark, 2023","volume":"28","author":"Johannesen","year":"2023","journal-title":"Euro Surveill"},{"key":"2025122403241795900_ciaf492-B10","doi-asserted-by":"crossref","first-page":"e0072923","DOI":"10.1128\/msphere.00729-23","article-title":"Clinical, microbiological, and molecular characterization of pediatric invasive infections by Streptococcus pyogenes in Spain in a context of global outbreak","volume":"9","author":"Ram\u00edrez de Arellano","year":"2024","journal-title":"mSphere"},{"key":"2025122403241795900_ciaf492-B11","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.3201\/eid3011.241068","article-title":"Invasive group A Streptococcus hypervirulent M1UK clone, Canada, 2018-2023","volume":"30","author":"Golden","year":"2024","journal-title":"Emerg Infect Dis"},{"key":"2025122403241795900_ciaf492-B12","first-page":"100873","article-title":"Increase in invasive group A streptococcal disease among Australian children coinciding with northern hemisphere surges","volume":"41","author":"Abo","year":"2023","journal-title":"Lancet Reg Health West Pac"},{"key":"2025122403241795900_ciaf492-B13","doi-asserted-by":"crossref","first-page":"102545","DOI":"10.1016\/j.jiph.2024.102545","article-title":"Post-pandemic increase in invasive group A strep infections in New Zealand","volume":"17","author":"Ammar","year":"2024","journal-title":"J Infect Public Health"},{"issue":"4","key":"2025122403241795900_ciaf492-B14","doi-asserted-by":"publisher","first-page":"847","DOI":"10.3201\/eid3104.241076","article-title":"Emerging Trends in Streptococcal Toxic Shock Syndrome, Japan","volume":"31","author":"Ujiie M","year":"2025","journal-title":"Emerg Infect Dis."},{"key":"2025122403241795900_ciaf492-B15","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/S0140-6736(22)01277-6","article-title":"Preparing for uncertainty: endemic paediatric viral illnesses after COVID-19 pandemic disruption","volume":"400","author":"Messacar","year":"2022","journal-title":"Lancet"},{"key":"2025122403241795900_ciaf492-B16","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1038\/s41467-024-47929-7","article-title":"Rapid expansion and international spread of M1UK in the post-pandemic UK upsurge of Streptococcus pyogenes","volume":"15","author":"Vieira","year":"2024","journal-title":"Nat Commun"},{"key":"2025122403241795900_ciaf492-B17","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofae457","article-title":"The emergence and impact of the M1UK lineage on invasive group A Streptococcus disease in Aotearoa New Zealand","volume":"11","author":"Vesty","year":"2024","journal-title":"Open Forum Infect Dis"},{"key":"2025122403241795900_ciaf492-B18","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/S1473-3099(19)30446-3","article-title":"Emergence of dominant toxigenic M1T1 Streptococcus pyogenes clone during increased scarlet fever activity in England: a population-based molecular epidemiological study","volume":"19","author":"Lynskey","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"2025122403241795900_ciaf492-B19","doi-asserted-by":"crossref","first-page":"e0063724","DOI":"10.1128\/jcm.00637-24","article-title":"Divergent effects of emm types 1 and 12 on invasive group A streptococcal infections-results of a retrospective cohort study, Germany 2023","volume":"62","author":"Bertram","year":"2024","journal-title":"J Clin Microbiol"},{"key":"2025122403241795900_ciaf492-B20","first-page":"76","article-title":"V\u00fdskyt sub-linie M1 UK mezi invazivn\u00edmi kmeny Streptococcus pyogenes typ emm1 izolovan\u00fdmi od prosince 2022 do kv\u011btna 2023 v \u010cesk\u00e9 republice [Prevalence of the M1UK sublineage among emm1 Streptococcus pyogenes invasive strains isolated in the Czech Republic from December 2022 to May 2023]","volume":"73","author":"Vesel\u00e1","year":"2024","journal-title":"Epidemiol Mikrobiol Imunol"},{"key":"2025122403241795900_ciaf492-B21","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/s41467-023-36717-4","article-title":"Detection of Streptococcus pyogenes M1UK in Australia and characterization of the mutation driving enhanced expression of superantigen SpeA","volume":"14","author":"Davies","year":"2023","journal-title":"Nat Commun"},{"key":"2025122403241795900_ciaf492-B22","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.3201\/eid1508.090264","article-title":"Predictors of death after severe Streptococcus pyogenes infection","volume":"15","author":"Lamagni","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"2025122403241795900_ciaf492-B23","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1371\/journal.ppat.0020005","article-title":"Genome-wide analysis of group a streptococci reveals a mutation that modulates global phenotype and disease specificity","volume":"2","author":"Sumby","year":"2006","journal-title":"PLoS Pathog"},{"key":"2025122403241795900_ciaf492-B24","doi-asserted-by":"crossref","first-page":"12057","DOI":"10.1038\/srep12057","article-title":"Consequences of the variability of the CovRS and RopB regulators among Streptococcus pyogenes causing human infections","volume":"5","author":"Fri\u00e3es","year":"2015","journal-title":"Sci Rep"},{"key":"2025122403241795900_ciaf492-B25","doi-asserted-by":"crossref","first-page":"2412745","DOI":"10.1080\/21505594.2024.2412745","article-title":"The intricate pathogenicity of Group A Streptococcus: a comprehensive update","volume":"15","author":"Bergsten","year":"2024","journal-title":"Virulence"},{"key":"2025122403241795900_ciaf492-B26","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1086\/432514","article-title":"Evolutionary origin and emergence of a highly successful clone of serotype M1 group A Streptococcus involved multiple horizontal gene transfer events","volume":"192","author":"Sumby","year":"2005","journal-title":"J Infect Dis"},{"key":"2025122403241795900_ciaf492-B27","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S1473-3099(20)30279-6","article-title":"M1UK lineage in invasive group A streptococcus isolates from the USA","volume":"20","author":"Li","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"2025122403241795900_ciaf492-B28","author":"NHS England","year":"2024"},{"key":"2025122403241795900_ciaf492-B29","author":"NHS England","year":"2024"},{"key":"2025122403241795900_ciaf492-B30","author":"NHS England"},{"key":"2025122403241795900_ciaf492-B31","author":"Office for Health Improvement & Disparities"},{"key":"2025122403241795900_ciaf492-B32","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.3201\/eid2905.221887","article-title":"Emerging invasive group A Streptococcus M1UK lineage detected by allele-specific PCR, England, 20201","volume":"29","author":"Zhi","year":"2023","journal-title":"Emerg Infect Dis"},{"key":"2025122403241795900_ciaf492-B33","first-page":"91","article-title":"An introduction to survival statistics: Kaplan-Meier analysis","volume":"7","author":"Dudley","year":"2016","journal-title":"J Adv Pract Oncol"},{"key":"2025122403241795900_ciaf492-B34","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1186\/cc2955","article-title":"Statistics review 12: survival analysis","volume":"8","author":"Bewick","year":"2004","journal-title":"Crit Care"},{"key":"2025122403241795900_ciaf492-B35","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1080\/00949650212847","article-title":"Empirical comparisons between Kaplan-Meier and Nelson-Aalen survival function estimators","volume":"72","author":"Colosimo","year":"2002","journal-title":"J Stat Comput Simul"},{"key":"2025122403241795900_ciaf492-B36","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.3201\/eid2910.230675","article-title":"Expansion of invasive group a streptococcus M1UK lineage in active bacterial core surveillance, United States, 2019\u20122021","volume":"29","author":"Li","year":"2023","journal-title":"Emerg Infect Dis"},{"key":"2025122403241795900_ciaf492-B37","article-title":"Characterization of emergent toxigenic M1UK \u00a0Streptococcus pyogenes and associated sublineages","volume":"9","author":"Li","year":"2023","journal-title":"Microb Genom"},{"key":"2025122403241795900_ciaf492-B38","first-page":"001277","article-title":"Molecular characterization of Streptococcus pyogenes (StrepA) non-invasive isolates during the 2022-2023 UK upsurge","volume":"10","author":"Hall","year":"2024","journal-title":"Microb Genom"},{"key":"2025122403241795900_ciaf492-B39","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1016\/S0140-6736(23)02095-0","article-title":"Surge of lower respiratory tract group A streptococcal infections in England in winter 2022: epidemiology and clinical profile","volume":"402","author":"Wrenn","year":"2023","journal-title":"Lancet"},{"key":"2025122403241795900_ciaf492-B40","doi-asserted-by":"crossref","first-page":"136","DOI":"10.23907\/2018.010","article-title":"The shock of strep: rapid deaths due to group A Streptococcus","volume":"8","author":"Thompson","year":"2018","journal-title":"Acad Forensic Pathol"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciaf492\/64705468\/ciaf492.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/81\/5\/e277\/64705468\/ciaf492.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/81\/5\/e277\/64705468\/ciaf492.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T08:24:25Z","timestamp":1766564665000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/81\/5\/e277\/8286278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,16]]},"references-count":40,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,10,16]]},"published-print":{"date-parts":[[2025,12,24]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciaf492","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,11,15]]},"published":{"date-parts":[[2025,10,16]]}}}